DCs in tumor tissues are known to play critical roles in tumor antigen cross-presentation and activating CD8+ T cells in the lymph nodes (119), which mediate the initiation of immune response and regulate the function of multiple immune cells (120). This evidence concerns the gene CD8A and neoplasm.